NASDAQ:AFIB Acutus Medical (AFIB) Stock Forecast, Price & News $0.85 0.00 (-0.22%) (As of 06/2/2023 06:55 PM ET) Add Compare Share Share Today's Range$0.78▼$0.8650-Day Range$0.66▼$1.0252-Week Range$0.48▼$2.15Volume62,400 shsAverage Volume156,268 shsMarket Capitalization$24.52 millionP/E RatioN/ADividend YieldN/APrice Target$2.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Acutus Medical MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside136.4% Upside$2.00 Price TargetShort InterestHealthy2.55% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.39) to ($1.51) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.13 out of 5 starsMedical Sector396th out of 980 stocksSurgical & Medical Instruments Industry38th out of 97 stocks 3.3 Analyst's Opinion Consensus RatingAcutus Medical has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.00, Acutus Medical has a forecasted upside of 136.4% from its current price of $0.85.Amount of Analyst CoverageAcutus Medical has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.55% of the float of Acutus Medical has been sold short.Short Interest Ratio / Days to CoverAcutus Medical has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Acutus Medical has recently increased by 6.34%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAcutus Medical does not currently pay a dividend.Dividend GrowthAcutus Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AFIB. Previous Next 2.2 News and Social Media Coverage News SentimentAcutus Medical has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Acutus Medical this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for AFIB on MarketBeat in the last 30 days. This is a decrease of -91% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Acutus Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Acutus Medical insiders have not sold or bought any company stock.Percentage Held by Insiders24.30% of the stock of Acutus Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 36.32% of the stock of Acutus Medical is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Acutus Medical are expected to grow in the coming year, from ($2.39) to ($1.51) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Acutus Medical is -1.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Acutus Medical is -1.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAcutus Medical has a P/B Ratio of 0.32. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Acutus Medical (NASDAQ:AFIB) StockAcutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.Read More Receive AFIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acutus Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AFIB Stock News HeadlinesMay 30, 2023 | americanbankingnews.comShort Interest in Acutus Medical, Inc. (NASDAQ:AFIB) Increases By 6.3%May 16, 2023 | finance.yahoo.comAcutus Medical, Inc. (NASDAQ:AFIB) Q1 2023 Earnings Call TranscriptJune 5, 2023 | Edge On The Street (Ad)AI is Unstoppable. Now Is The Time!AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.May 15, 2023 | finance.yahoo.comAcutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023May 12, 2023 | finance.yahoo.comQ1 2023 Acutus Medical Inc Earnings CallMay 11, 2023 | msn.comAcutus Medical: Q1 Earnings InsightsMay 11, 2023 | finance.yahoo.comAcutus Medical Reports First Quarter 2023 Financial ResultsMay 9, 2023 | americanbankingnews.comAcutus Medical (AFIB) to Release Earnings on ThursdayJune 5, 2023 | Edge On The Street (Ad)AI is Unstoppable. Now Is The Time!AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.April 30, 2023 | americanbankingnews.comAcutus Medical (NASDAQ:AFIB) Trading Up 2.7%April 28, 2023 | finance.yahoo.comAcutus Medical to Announce First Quarter 2023 Financial ResultsApril 20, 2023 | seekingalpha.comAcutus Medical gives prelim Q1 reportsApril 20, 2023 | msn.comAcutus Medical reports prelim Q1 resultsApril 20, 2023 | finance.yahoo.comRECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation TherapyApril 20, 2023 | finance.yahoo.comAcutus Medical Announces Preliminary Unaudited First Quarter 2023 ResultsApril 20, 2023 | msn.comCatheter ablation for A-fib may reduce risk of mental decline, dementiaApril 17, 2023 | finance.yahoo.comAcutus Medical, Inc. (NASDAQ:AFIB) Might Not Be As Mispriced As It Looks After Plunging 25%April 1, 2023 | americanbankingnews.comAcutus Medical, Inc. (NASDAQ:AFIB) Sees Significant Increase in Short InterestMarch 22, 2023 | markets.businessinsider.comBTIG Sticks to Its Buy Rating for Acutus Medical (AFIB)March 18, 2023 | markets.businessinsider.comBTIG Sticks to Their Buy Rating for Acutus Medical (AFIB)March 18, 2023 | finance.yahoo.comAcutus Medical, Inc. (NASDAQ:AFIB) Q4 2022 Earnings Call TranscriptMarch 16, 2023 | msn.comAcutus Medical GAAP EPS of $0.41 beats by $1.12, revenue of $5M beats by $0.45MMarch 16, 2023 | finance.yahoo.comAcutus Medical Reports Fourth Quarter and Full Year 2022 Financial ResultsMarch 16, 2023 | finance.yahoo.comAcutus Medical, Inc. (AFIB) Q4 Earnings and Revenues Surpass EstimatesMarch 16, 2023 | marketwatch.comAfib Heart Devices Market [2023-2028] | Latest Study on Global Industry Trends & Future ForecastMarch 15, 2023 | benzinga.comAcutus Medical's Earnings: A PreviewMarch 9, 2023 | finance.yahoo.comAcutus Medical to Announce Fourth Quarter and Full Year 2022 Financial ResultsSee More Headlines AFIB Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AFIB Company Calendar Last Earnings3/16/2023Today6/05/2023Next Earnings (Estimated)8/10/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AFIB CUSIPN/A CIK1522860 Webwww.acutusmedical.com Phone442-232-6080Fax442-232-6081Employees291Year Founded2011Price Target and Rating Average Stock Price Forecast$2.00 High Stock Price Forecast$2.50 Low Stock Price Forecast$1.50 Forecasted Upside/Downside+136.4%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-39,620,000.00 Net Margins-94.43% Pretax Margin-93.95% Return on Equity-23.58% Return on Assets-12.67% Debt Debt-to-Equity Ratio0.57 Current Ratio5.95 Quick Ratio5.08 Sales & Book Value Annual Sales$16.85 million Price / Sales1.45 Cash FlowN/A Price / Cash FlowN/A Book Value$2.09 per share Price / Book0.40Miscellaneous Outstanding Shares28,976,000Free Float21,935,000Market Cap$24.51 million OptionableNot Optionable Beta0.81 Social Links Key ExecutivesMr. R. Scott Huennekens CPA (Age 58)M.B.A., Exec. Chairman Comp: $121kMr. David Harrison Roman (Age 40)CEO, Pres & Director Comp: $679.4kMr. Vincent J. Burgess (Age 57)Consultant Comp: $583.5kMr. Takeo MukaiVP of Fin. & Accounting and Interim CFODr. Graydon E. Beatty (Age 65)Chief Technology Officer Dr. Derrick Chou Ph.D.Chief Technology OfficerMr. Tom Sohn (Age 47)Sr. VP, Gen. Counsel & Sec. Mr. Shibaji Shome Ph.D.VP of MarketingMr. Charlie Piscitello (Age 59)Sr. VP & Chief People Officer Mr. Gary W. Doherty (Age 56)Sr. VP of Fin. More ExecutivesKey CompetitorsenVVeno MedicalNASDAQ:NVNOVapothermNYSE:VAPOBrainsWayNASDAQ:BWAYSTRATA Skin SciencesNASDAQ:SSKNCo-DiagnosticsNASDAQ:CODXView All CompetitorsInstitutional OwnershipSchonfeld Strategic Advisors LLCBought 155,500 shares on 5/15/2023Ownership: 0.587%Belvedere Trading LLCSold 5,600 shares on 5/15/2023Ownership: 0.000%Renaissance Technologies LLCBought 90,300 shares on 5/12/2023Ownership: 1.362%Cerity Partners LLCBought 63,698 shares on 5/11/2023Ownership: 0.220%View All Institutional Transactions AFIB Stock - Frequently Asked Questions Should I buy or sell Acutus Medical stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acutus Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AFIB shares. View AFIB analyst ratings or view top-rated stocks. What is Acutus Medical's stock price forecast for 2023? 2 brokerages have issued twelve-month target prices for Acutus Medical's shares. Their AFIB share price forecasts range from $1.50 to $2.50. On average, they anticipate the company's share price to reach $2.00 in the next year. This suggests a possible upside of 136.4% from the stock's current price. View analysts price targets for AFIB or view top-rated stocks among Wall Street analysts. How have AFIB shares performed in 2023? Acutus Medical's stock was trading at $1.15 on January 1st, 2023. Since then, AFIB shares have decreased by 26.4% and is now trading at $0.8460. View the best growth stocks for 2023 here. Are investors shorting Acutus Medical? Acutus Medical saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 493,200 shares, an increase of 6.3% from the April 30th total of 463,800 shares. Based on an average daily volume of 133,900 shares, the days-to-cover ratio is presently 3.7 days. Approximately 2.6% of the company's shares are sold short. View Acutus Medical's Short Interest. When is Acutus Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023. View our AFIB earnings forecast. How were Acutus Medical's earnings last quarter? Acutus Medical, Inc. (NASDAQ:AFIB) issued its quarterly earnings results on Thursday, March, 16th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.70) by $1.11. The firm had revenue of $4.96 million for the quarter, compared to the consensus estimate of $4.80 million. Acutus Medical had a negative trailing twelve-month return on equity of 23.58% and a negative net margin of 94.43%. What guidance has Acutus Medical issued on next quarter's earnings? Acutus Medical issued an update on its FY 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $19.00 million-$21.00 million, compared to the consensus revenue estimate of $19.64 million. What other stocks do shareholders of Acutus Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Acutus Medical investors own include Oak Street Health (OSH), Alibaba Group (BABA), Checkmate Pharmaceuticals (CMPI), Salesforce (CRM), Walt Disney (DIS), DocuSign (DOCU), Marvell Technology (MRVL), NVIDIA (NVDA), Tesla (TSLA) and Twilio (TWLO). When did Acutus Medical IPO? (AFIB) raised $126 million in an IPO on Thursday, August 6th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. What is Acutus Medical's stock symbol? Acutus Medical trades on the NASDAQ under the ticker symbol "AFIB." Who are Acutus Medical's major shareholders? Acutus Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (1.36%), Schonfeld Strategic Advisors LLC (0.59%), Cerity Partners LLC (0.22%) and Belvedere Trading LLC (0.00%). Insiders that own company stock include James F Hinrichs, Orbimed Advisors Llc and R Scott Huennekens. View institutional ownership trends. How do I buy shares of Acutus Medical? Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Acutus Medical's stock price today? One share of AFIB stock can currently be purchased for approximately $0.85. How much money does Acutus Medical make? Acutus Medical (NASDAQ:AFIB) has a market capitalization of $24.51 million and generates $16.85 million in revenue each year. The company earns $-39,620,000.00 in net income (profit) each year or ($0.72) on an earnings per share basis. How many employees does Acutus Medical have? The company employs 291 workers across the globe. Does Acutus Medical have any subsidiaries? The following companies are subsidiares of Acutus Medical: Acutus Medical N.V..Read More How can I contact Acutus Medical? Acutus Medical's mailing address is 2210 FARADAY AVE SUITE 100, CARLSBAD CA, 92008. The official website for the company is www.acutusmedical.com. The company can be reached via phone at 442-232-6080, via email at investors@acutusmedical.com, or via fax at 442-232-6081. This page (NASDAQ:AFIB) was last updated on 6/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.